Walden Group Healthcare M&A Blog

  • Boston Scientific Announces Acquisition Of nVision Medical Corporation

    04/17/2018
    Boston Scientific Corporation, a $8.83b manufacturer of medical devices for cardiovascular, digestive, pulmonary and other interventional specialties is acquiring nVision Medical, a developer of a device for collecting cells from the fallopian tubes to detect ovarian cancer. Ovarian cancer is the fifth leading cause of cancer death among women....
    Read More
  • Johnson & Johnson Acquired Orthotaxy to Develop a Robotic-Assisted Orthopedic Surgery Solution

    4/17/2018
    With its acquisition of Orthotaxy, Johnson & Johnson joins a growing list of medtech players strengthening surgical robotics offerings expanding the technology's applications.  Orthotaxy's is in early-stage development for total and partial knee replacement.  The deal helps J&J compete more effectively against Stryker’s Mako...
    Read More
  • Roche acquires Flatiron Health for $1.9b

    04/05/2018
    Roche Holding AG, a $54.1b research-focused, biotechnology company is acquiring Flatiron Health, a developer of an OncologyCloud platform which includes medical record for oncology, advanced analytics, patient portal and integrated billing for $1.9b. Flatiron’s cancer-centric electronic health records platform is connected to about 250...
    Read More
  • Allergan to Acquire Elastagen's Next Generation Injectable Portfolio for $95m

    04/12/2018
    Allergan Plc, a $15.9b provider of medical aesthetics, biosimilars, and over-the-counter pharmaceutical products will acquire Elastagen Pty Ltd., a provider of advanced tissue repair platform based on tropoelastin (gives tissue its elasticity) for $95m. The acquisition adds proprietary injectable products to Allergan's existing portfolio....
    Read More
  • Boston Scientific Corporation acquires Millipede, Inc. for $90m

    02/21/2018
    Boston Scientific Corporation, a $8.83b manufacturer of medical devices for cardiovascular, digestive, pulmonary and other interventional specialties is acquiring Millipede, Inc., a developer of transcatheter, semi-rigid, complete annuloplasty ring for the treatment of heart disease for $90m. Millipede IRIS' annuloplasty ring which is...
    Read More
  • Page 1 of 712345...Last »